We are live on ! Find out more
UBIO

Proshares UltraPro NASDAQ Biotechnology
UBIO

Delisted

UBIO was delisted on the 27th of March, 2020.

Back to rankings

4 hedge funds and large institutions have $293K invested in Proshares UltraPro NASDAQ Biotechnology in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.18% less ownership

Funds ownership: 4.66% → 1.48% (-3.2%)

33% less funds holding

Funds holding: 6 → 4 (-2)

80% less capital invested

Capital invested by funds: $1.45M → $293K (-$1.16M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $4K

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
$4K
Net Calls
-$4K
Net Calls Change
-$293K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$553K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$391K
3
UBS Group
UBS Group
Switzerland
-$47.8K
4
TRCT
Tower Research Capital (TRC)
New York
-$40.9K

UBIO Hedge Fund Activity: Q3 2019 in Review

4 of the 4,575 institutional investors tracked by Wall St. Rank reported a position in Proshares UltraPro NASDAQ Biotechnology (UBIO) for Q3 2019, worth a combined $293K — down 80% from $1.45M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of UBIO and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Jane Street, exiting entirely with an estimated $553K sold.

  • 4 institutional investors held Proshares UltraPro NASDAQ Biotechnology (UBIO) as of Q3 2019, down from 6 in Q2 2019.
  • Funds reported $293K of Proshares UltraPro NASDAQ Biotechnology stock for Q3 2019, down 80% quarter-over-quarter.
  • 0 funds opened new Proshares UltraPro NASDAQ Biotechnology positions in Q3 2019 and 2 closed out, a net change of -2 holders.
  • The largest Proshares UltraPro NASDAQ Biotechnology seller in Q3 2019 was Jane Street, an estimated $553K sold.

Based on aggregated 13F filings for Q3 2019.